拜玛林制药(BMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BMRN 拜玛林制药

盘后交易 01-27 19:20:23 EST

117.27

+0.29

+0.25%

盘后117.76

+0.49+0.42%

16:41 EST

最高117.77	最低116.81	成交量121.72万
今开117.00	昨收116.98	日振幅0.82%
总市值217.95亿	流通市值216.55亿	总股本1.86亿
成交额1.43亿	换手率0.66%	流通股本1.85亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BMRN","market":"US","secType":"STK","nameCN":"拜玛林制药","latestPrice":117.27,"timestamp":1674853200000,"preClose":116.98,"halted":0,"volume":1217209,"hourTrading":{"tag":"盘后","latestPrice":117.76,"preClose":117.27,"latestTime":"16:41 EST","volume":52789,"amount":6190568.141559999,"timestamp":1674855700507},"delay":0,"floatShares":184657734,"shares":185848915,"eps":0.452949,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.29,"latestTime":"01-27 19:20:23 EST","open":117,"high":117.77,"low":116.81,"amount":142758244.490176,"amplitude":0.008207,"askPrice":118,"askSize":50,"bidPrice":115,"bidSize":3,"shortable":3,"etf":0,"ttmEps":0.452949,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1674867600000},"adr":0,"listingDate":932702400000,"adjPreClose":116.98,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":116,"preClose":116.98,"latestTime":"09:28 EST","volume":13,"amount":1515.8,"timestamp":1674829688120},"postHourTrading":{"tag":"盘后","latestPrice":117.76,"preClose":117.27,"latestTime":"16:41 EST","volume":52789,"amount":6190568.141559999,"timestamp":1674855700507},"volumeRatio":0.805471},"requestUrl":"/m/hq/s/BMRN/","defaultTab":"news","newsList":[{"id":"2304665581","title":"Biomarin Pharmaceutical(BMRN.US)获加拿大投资银行集团首次覆盖，给予持有评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2304665581","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2304665581?lang=zh_CN&edition=full","pubTime":"2023-01-19 07:40","pubTimestamp":1674085236,"startTime":"0","endTime":"0","summary":"Biomarin Pharmaceutical获加拿大投资银行集团首次覆盖，给予持有评级, 目标价119.00美元。拜玛林制药公司简介：BioMarin Pharmaceutical, Inc.是一家生物技术公司,主要开发和商业化治疗严重和威胁生命的罕见疾病和医疗条件的人。其产品包括Aldurazyme, Brineura, Kuvan, Naglazyme, Palynziq和Vimizim。公司由Christopher M. Starr和Grant W. Denison于1997年3月21日创立,总部位于加州圣拉斐尔。以上内容由证券之星根据公开信息整理，与本站立场无关。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230119074539840664bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230119074539840664bb&s=b","is_publish_highlight":false},{"id":"2275938428","title":"加拿大皇家银行:维持Biomarin Pharmaceutical(BMRN.US)与大盘持平评级, 目标价由90.00美元调整至95.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2275938428","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2275938428?lang=zh_CN&edition=full","pubTime":"2022-10-13 20:54","pubTimestamp":1665665657,"startTime":"0","endTime":"0","summary":"【加拿大皇家银行：维持Biomarin Pharmaceutical(BMRN.US)与大盘持平评级, 目标价由90.00美元调整至95.00美元】加拿大皇家银行：维持Biomarin Pharmaceutical(BMRN.US)与大盘持平评级, 目标价由90.00美元调整至95.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022101320561883ec5620&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022101320561883ec5620&s=b","is_publish_highlight":false},{"id":"2257490741","title":"巴克莱:维持Biomarin Pharmaceutical(BMRN.US)增持评级, 目标价由112.00美元调整至125.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2257490741","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2257490741?lang=zh_CN&edition=full","pubTime":"2022-08-04 19:30","pubTimestamp":1659612624,"startTime":"0","endTime":"0","summary":"【巴克莱：维持Biomarin Pharmaceutical(BMRN.US)增持评级, 目标价由112.00美元调整至125.00美元】巴克莱：维持Biomarin Pharmaceutical(BMRN.US)增持评级, 目标价由112.00美元调整至125.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080419322683d5642e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022080419322683d5642e&s=b","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0712},{"period":"1month","weight":0.1451},{"period":"3month","weight":0.3482},{"period":"6month","weight":0.3594},{"period":"1year","weight":0.3976},{"period":"ytd","weight":0.1304}],"websiteUrl":"http://www.bmrn.com","compareEarnings":[{"period":"1week","weight":0.0415},{"period":"1month","weight":0.0612},{"period":"3month","weight":0.0404},{"period":"6month","weight":-0.0176},{"period":"1year","weight":-0.0661},{"period":"ytd","weight":0.0584}],"name":"拜玛林制药","description":"Biomarin Pharmaceutical Inc.位于特拉华州，研发生产创新生物技术药物，治疗严重的疾病和健康问题。拜玛琳公司选择候选产品时，选择还未解决的具有重大意义的疾病和问题，对生物学有充分的认识，有机会率先面市或者使现有产品得到重大改进。公司产品组合包括四项定型产品和多项临床试验的候选产品。公司的定型产品分别是Naglazyme（加硫酶），Kuvan（二盐酸沙丙蝶呤），Firdapse（药磷酸阿米吡啶）和Aldurazyme（拉罗尼酶）。公司于1996年在特拉华州注册，于1997年3月21号运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.708333,"avgChangeRate":0.059591},{"month":2,"riseRate":0.478261,"avgChangeRate":0.016427},{"month":3,"riseRate":0.478261,"avgChangeRate":0.006187},{"month":4,"riseRate":0.565217,"avgChangeRate":-0.013222},{"month":5,"riseRate":0.565217,"avgChangeRate":0.018011},{"month":6,"riseRate":0.652174,"avgChangeRate":0.017437},{"month":7,"riseRate":0.608696,"avgChangeRate":0.04072},{"month":8,"riseRate":0.5,"avgChangeRate":-0.003095},{"month":9,"riseRate":0.5,"avgChangeRate":-0.000546},{"month":10,"riseRate":0.458333,"avgChangeRate":-0.02332},{"month":11,"riseRate":0.791667,"avgChangeRate":0.06205},{"month":12,"riseRate":0.625,"avgChangeRate":0.034001}],"exchange":"NASDAQ","nameEN":"Biomarin Pharmaceutical","compareStock":{"symbol":"SPY","name":"标普500ETF"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.11.10","shortVersion":"4.11.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"拜玛林制药(BMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供拜玛林制药(BMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"拜玛林制药,BMRN,拜玛林制药股票,拜玛林制药股票老虎,拜玛林制药股票老虎国际,拜玛林制药行情,拜玛林制药股票行情,拜玛林制药股价,拜玛林制药股市,拜玛林制药股票价格,拜玛林制药股票交易,拜玛林制药股票购买,拜玛林制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"拜玛林制药(BMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供拜玛林制药(BMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}